# Elevance Health (ELV) — Analyst Forecast

ELV · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/elv/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | Guggenheim | Maintained | Buy | $460.00 |
| Oct 7, 2026 | Barclays | Maintained | Overweight | $469.00 |
| Jul 17, 2026 | Leerink Partners | Maintained | Market Perform | $395.00 |
| Jul 16, 2026 | Baird | Maintained | Neutral | $393.00 |
| Jul 16, 2026 | Barclays | Maintained | Overweight | $457.00 |
| Jul 16, 2026 | Guggenheim | Maintained | Buy | $455.00 |
| Jul 16, 2026 | Wells Fargo | Maintained | Overweight | $473.00 |
| Jul 16, 2026 | RBC Capital | Maintained | Sector Perform | $424.00 |
| Jul 14, 2026 | Truist Securities | Maintained | Buy | $475.00 |
| Jul 14, 2026 | TD Cowen | Maintained | Buy | $465.00 |
| Jul 13, 2026 | Wells Fargo | Maintained | Overweight | $492.00 |
| Jul 9, 2026 | RBC Capital | Maintained | Sector Perform | $439.00 |
| Jul 7, 2026 | Cantor Fitzgerald | Maintained | Overweight | $450.00 |
| Jul 2, 2026 | Bernstein | Maintained | Outperform | $482.00 |
| Jun 8, 2026 | JP Morgan | Maintained | Overweight | $476.00 |
| Jun 8, 2026 | Mizuho | Maintained | Outperform | $465.00 |
| Jun 4, 2026 | Morgan Stanley | Maintained | Equal-Weight | $404.00 |
| Jun 4, 2026 | B of A Securities | Maintained | Buy | $460.00 |
| Jun 1, 2026 | Truist Securities | Maintained | Buy | $450.00 |
| May 26, 2026 | Barclays | Maintained | Overweight | $480.00 |

## Frequently Asked Questions

### What is the latest analyst rating on ELV?

On Oct 12, 2026, Guggenheim maintained Elevance Health at Buy with a price target of $460.00.

## Similar Stocks

- [CNC](https://www.lighthorse.io/tickers/cnc) — Centene Corporation Common Stock
- [MOH](https://www.lighthorse.io/tickers/moh) — Molina Healthcare Inc Common Stock
- [UNH](https://www.lighthorse.io/tickers/unh) — UnitedHealth Group Incorporated Common Stock (DE)

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).